Showing results (141-150 of 173) with videos related to
Sort By:
Pageof 18
Oncology|March 1, 1997
Phase II evaluation of 5-fluourouracil plus folinic acid and alpha 2b-interferon in metastatic colorectal cancerC H Köhne, H Wilke, W Hiddemann, et al.Leukemia|June 1, 1996
De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significanceB Gahn, D Haase, M Unterhalt, et al.British Journal of Haematology|May 8, 1999
Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcomeF Griesinger, M Pirò-Noack, N Kaib, et al.Leukemia|August 1, 1996
Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factorC Schoch, D Haase, T Haferlach, et al.Blood|June 17, 1998
MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosisM H Dreyling, K Schrader, C Fonatsch, et al.Leukemia Research|August 7, 2007
Amsacrine containing induction therapy in elderly AML patients: comparison to standard induction regimens in a matched-pair analysisT Kessler, M Mohr, C Müller-Tidow, et al.British Journal of Haematology|December 24, 1997
The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study GroupC Schoch, D Haase, C Fonatsch, et al.British Journal of Haematology|March 21, 1998
Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12B Streubel, C Sauerland, G Heil, et al.Journal of Cancer Research and Clinical Oncology|June 11, 1999
Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromesW Verbeek, B Wörmann, P Koch, et al.Praxis|April 13, 1999
[Treatment of adult acute lymphoblastic leukemia]N Gökbuget, R Arnold, T Büchner, et al.Pageof 18